Table 1 Characteristics of the patients with NSCLC.

From: Regulatory (FoxP3+) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer

Characteristics

Discovery cohort (n = 83)

Validation cohort (n = 49)

Age—yr

 Median

62

62

 Range

39–88

34–82

Gender no. (%)

 Male

68 (81.9)

37 (75.5)

 Female

15 (18.1)

12 (24.5)

ECOG performance-status score—no. (%)

 0

0 (0)

2 (4)

 1

74 (89.2)

39 (79.6)

  ≥ 2

9 (10.8)

8 (16.4)

Tumor histologic type—no. (%)

 Adenocarcinoma

48 (57.8)

25 (51)

 Squamous cell carcinoma

26 (31.3)

13 (26.5)

 Others

9 (10.9)

11 (22.5)

PD-L1 expression level – no. (%)

  < 1%

15 (18)

8 (16.3)

  ≥ 1%

57 (68.7)

27 (55.1)

 Unknown

11 (13.3)

14 (28.6)

  1. ECOG Eastern Cooperative Oncology Group.